Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1994 1
1995 1
1996 3
1997 2
1998 4
1999 9
2000 13
2001 10
2002 16
2003 26
2004 25
2005 34
2006 48
2007 36
2008 38
2009 63
2010 68
2011 102
2012 114
2013 148
2014 161
2015 188
2016 189
2017 225
2018 227
2019 194
2020 191
2021 53
Text availability
Article attribute
Article type
Publication date

Search Results

1,935 results
Results by year
Filters applied: . Clear all
Page 1
Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2.
Baek YH, Um J, Antigua KJC, Park JH, Kim Y, Oh S, Kim YI, Choi WS, Kim SG, Jeong JH, Chin BS, Nicolas HDG, Ahn JY, Shin KS, Choi YK, Park JS, Song MS. Baek YH, et al. Among authors: jeong jh. Emerg Microbes Infect. 2020 Dec;9(1):998-1007. doi: 10.1080/22221751.2020.1756698. Emerg Microbes Infect. 2020. PMID: 32306853 Free PMC article.
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
Kim H, Alten R, Avedano L, Dignass A, Gomollón F, Greveson K, Halfvarson J, Irving PM, Jahnsen J, Lakatos PL, Lee J, Makri S, Parker B, Peyrin-Biroulet L, Schreiber S, Simoens S, Westhovens R, Danese S, Jeong JH. Kim H, et al. Among authors: jeong jh. Drugs. 2020 Feb;80(2):99-113. doi: 10.1007/s40265-020-01256-5. Drugs. 2020. PMID: 32002851 Free PMC article. Review.
Stereotactic body radiation therapy for locally advanced pancreatic cancer.
Jung J, Yoon SM, Park JH, Seo DW, Lee SS, Kim MH, Lee SK, Park DH, Song TJ, Ryoo BY, Chang HM, Kim KP, Yoo C, Jeong JH, Kim SC, Hwang DW, Lee JH, Song KB, Jo YY, Park J, Kim JH. Jung J, et al. Among authors: jeong jh. PLoS One. 2019 Apr 12;14(4):e0214970. doi: 10.1371/journal.pone.0214970. eCollection 2019. PLoS One. 2019. PMID: 30978229 Free PMC article.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Mamounas EP, Bandos H, Lembersky BC, Jeong JH, Geyer CE Jr, Rastogi P, Fehrenbacher L, Graham ML, Chia SK, Brufsky AM, Walshe JM, Soori GS, Dakhil SR, Seay TE, Wade JL 3rd, McCarron EC, Paik S, Swain SM, Wickerham DL, Wolmark N. Mamounas EP, et al. Among authors: jeong jh. Lancet Oncol. 2019 Jan;20(1):88-99. doi: 10.1016/S1470-2045(18)30621-1. Epub 2018 Nov 30. Lancet Oncol. 2019. PMID: 30509771 Free PMC article. Clinical Trial.
1,935 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page